Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Capital Expenditures: 2022-2024

Historic Capital Expenditures for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to $481,000.

  • Lexeo Therapeutics' Capital Expenditures rose 68.00% to $42,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $115,000, marking a year-over-year change of. This contributed to the annual value of $481,000 for FY2024, which is 318.26% up from last year.
  • Lexeo Therapeutics' Capital Expenditures amounted to $481,000 in FY2024, which was up 318.26% from $115,000 recorded in FY2023.
  • Over the past 5 years, Lexeo Therapeutics' Capital Expenditures peaked at $672,000 during FY2022, and registered a low of $115,000 during FY2023.
  • In the last 3 years, Lexeo Therapeutics' Capital Expenditures had a median value of $481,000 in 2024 and averaged $422,667.
  • Per our database at Business Quant, Lexeo Therapeutics' Capital Expenditures tumbled by 82.89% in 2023 and then skyrocketed by 318.26% in 2024.
  • Yearly analysis of 3 years shows Lexeo Therapeutics' Capital Expenditures stood at $672,000 in 2022, then slumped by 82.89% to $115,000 in 2023, then skyrocketed by 318.26% to $481,000 in 2024.